X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218306
https://www.fiercepharma.com/pharma/despite-exclusivity-loss-takeda-treads-water-vyvanse-generics-circle
https://www.fiercepharma.com/pharma/times-takedas-vyvanse-patents-clearing-way-several-newly-fda-approved-generics-amid-shortage
https://www.prnewswire.com/news-releases/mallinckrodt-receives-us-fda-approval-for-lisdexamfetamine-dimesylate-capsules-and-launches-product-used-to-treat-attention-deficithyperactivity-disorder-adhd-301914308.html
https://www.fiercepharma.com/pharma/takeda-hypes-dengue-vaccine-vyvanse-generics-loom
https://www.fiercepharma.com/manufacturing/takeda-reports-vyvanse-shortage
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214134
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217442
https://www.fiercepharma.com/pharma/takeda-braces-impact-vyvanse-edges-toward-patent-cliff
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215415
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202830
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202802
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214547
https://endpts.com/takeda-boots-a-top-prospect-out-of-its-late-stage-pipeline-while-another-is-delayed-by-war-lockdown/
https://www.raps.org/news-and-articles/news-articles/2019/9/fda-consults-on-abuse-deterrent-cns-stimulants
http://www.nasdaq.com/article/shires-shpg-adhd-candidates-nda-accepted-by-fda-cm736281
http://www.fiercepharma.com/pharma/medicare-medcaid-pony-up-for-big-price-hikes-2015-data-show
http://www.fiercepharma.com/marketing/weight-loss-peers-flailing-shire-keeps-growing-vyvanse-bed
http://cphi-online.com/shire-submits-nda-to-fda-for-new-formulation-of-news040087.html
http://www.fiercepharma.com/story/baxalta-hand-shires-not-looking-buy-sell-maybe/2016-02-11
http://www.pharmatimes.com/Article/15-09-25/Shire_victorious_in_US_Vyvanse_patent_battle.aspx
http://www.pharmatimes.com/Article/15-09-07/Seven_new_medicines_approved_for_NHS_Scotland.aspx
http://www.pharmatimes.com/Article/15-08-27/First_stimulant_for_ADHD_in_adults_gets_UK_launch.aspx?
http://www.fiercepharmamarketing.com/story/vyvanse-set-steal-adhd-share-back-school-meds-rush/2015-08-19
http://mobile.nytimes.com/2015/04/19/us/workers-seeking-productivity-in-a-pill-are-abusing-adhd-drugs.html?_r=1
http://www.thestar.com/news/canada/2015/03/30/health-canada-issues-stronger-clearer-warnings-about-suicide-risks-linked-to-adhd-drugs.html
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52759a-eng.php
http://www.fiercepharmamarketing.com/story/shires-vyvanse-brand-team-draws-fire-aggressive-binge-eating-push/2015-02-25
http://www.bloomberg.com/news/articles/2015-01-30/binge-eating-added-to-list-of-uses-for-shire-drug-by-fda
http://www.shire.com/shireplc/en/investors/investorsnews/irshirenews?id=1059
http://www.fiercepharma.com/story/supreme-court-pitches-patent-fight-over-shires-lialda-after-teva-ruling/2015-01-26
http://www.shire.com/shireplc/en/investors/investorsnews/irshirenews?id=1055
http://www.medpagetoday.com/Psychiatry/EatingDisorders/49524?xid=nl_mpt_DHE_2015-01-15&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=ST&eun=g655567d0r&userid=655567&email=pharmalot%40gmail.com&mu_id=5789356&utm_term=Daily
Market Place
Share 
